Component

Brusatol

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Brusatol treatment significantly diminished the ME-D-induced increase in NQO1 expression in BEAS-2B cells, supporting NRF2 dependence for that measured response.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    dose
    ME-D with brusatol
    duration
    Acute
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Human BEAS-2B cells
    limitations
    Brusatol is a pharmacological perturbation with effects beyond a nutritional setting; the experiment supports pathway dependence for NQO1, not every effect of Moringa.
    nutrient_topic
    Moringa oleifera chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Moringa oleifera
    organism
    Human BEAS-2B cells
    plain_language
    Brusatol treatment significantly diminished the ME-D-induced increase in NQO1 expression in BEAS-2B cells, supporting NRF2 dependence for that measured response.
    primary_references
    Development of Moringa oleifera as functional food targeting NRF2 signaling: antioxidant and anti-inflammatory activity in experimental model systems. (2023). https://pubmed.ncbi.nlm.nih.gov/37114361/ DOI: 10.1039/d3fo00572k
    route
    In vitro perturbation
    tissue
    Pharmacological NRF2 perturbation
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Moringa oleifera: mechanism of action and interactions (2026-09-20) · lines 79–88

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Human BEAS-2B cells · source_derived_draft · unverified_draft

    ## moringa-brusatol-blocks-nrf2-response Brusatol treatment significantly diminished the ME-D-induced increase in NQO1 expression in BEAS-2B cells, supporting NRF2 dependence for that measured response. Model/species: Human BEAS-2B cells Tissue/system: Pharmacological NRF2 perturbation Exposure: ME-D with brusatol Route: In vitro perturbation Duration: Acute Limits: Brusatol is a pharmacological perturbation with effects beyond a nutritional setting; the experiment supports pathway dependence for NQO1, not every effect of Moringa. Primary reference: Development of Moringa oleifera as functional food targeting NRF2 signaling: antioxidant and anti-inflammatory activity in experimental model systems. (2023). https://pubmed.ncbi.nlm.nih.gov/37114361/ DOI: 10.1039/d3fo00572k Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards